Document is current
Any future updates will be listed below
-
Authors
Notarantonio, Anne-Béatrice
Bertrand, Allan
Piucco, Romain
Fievet, Ghislain
Sartelet, Hervé
Boulangé, Laura
de Isla, Natalia
De Carvalho Bittencourt, Marcelo
Hergalant, Sébastien
Rubio, Marie-Thérèse
D’Aveni, Maud
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03357172 at ClinicalTrials.govDocuments that mention this clinical trial
Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation
https://doi.org/10.1186/s40164-024-00516-4
-
Funding
Funding for this research was provided by:
Ligue Contre le Cancer
- License Information
-
More Information
Article History
Received: 1 December 2023
Accepted: 27 April 2024
First Online: 11 May 2024
Declarations
:
: This study was approved by an ethics committee (CPP OUEST II le 05/02/2019) and was identified as clinical trial NCT03357172 (“REAL-GREFFE”).
: All the patients prospectively included in this study signed an informed consent form.
: The authors declare no competing financial interests related to this work.
